Isolated office hypertension: Association with target organ damage and cardiovascular risk indices

Journal of the National Medical Association

Volumn 98, Issue 4, 2006, Pages 601-606

  Kamel, Nuri ^a,b   Gursoy, Alptekin ^a,b   Koseoglulari, Osman ^a,b   Dincer, Irem ^a,b   Gullu, Sevim ^a,b  

^a Ankara University ^*

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Cardiovascular; Hypertension; Lipids

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTERIAL PRESSURE; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EVALUATION; FEMALE; HUMAN; HYPERTENSION; ISOLATED OFFICE HYPERTENSION; MALE; MICROALBUMINURIA; OCCUPATIONAL DISEASE; PRIORITY JOURNAL;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; OFFICE VISITS; RISK FACTORS; VISCERA;

EID: 33645664194     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Owens P, Atkins N, O'Brien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension. 1999;34:267-272.
2. Myers MG, Tobe SW, McKay DW, et al. New Algorithm for the Diagnosis of Hypertension Canadian Hypertension Education Program Recommendations (2005). Am J Hypertens. 2005;18:1369-1374.
3. Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA. 1988;259:225-228.
4. Verdecchia P, Schillaci G, Borgioni C, et al. White coat hypertension and white coat effect: similarities and differences. Am J Hypertens. 1995;8:790-798.
5. Gcsse P, Promax H, Durandet P, et al. White coat hypertension. No harm for the heart. Hypertension. 1993;22:766-770.
6. Guida L, Iannuzzi R, Crivaro M, et al. Clinic daytime blood pressure differences and cardiovascular damage. J Hypertens. 1999;17:331-337.
7. Pierdomenico SD, Lapenna D, Guglielmi MD, et al. Target organ status and serum lipids in patients with white coat hypertension. Hypertension. 1995;26:801-807.
8. Prencipe G, Pellegrino L. White-coat arterial hypertension and stable borderline essential arterial hypertension. An ultrasonic study of the carotid arteries. Minerva Cardioangiol. 1998;46:149-155.
9. Pierdomenico SD, Cipollone F, Lapenna D, et al. Endothelial function in sustained and white coat hypertension. Am J Hypertens. 2002;15:946-952.
10. Cardillo C, De Felice F, Campia U, et al. Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension. Hypertension. 1993;21:836-844.
11. Glen SK, Elliott HL, Curzio JL, et al. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet. 1996;348:654-657.
12. Owens PE, Lyons SP, Rodriguez SA, et al. Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ changes? J Hum Hypertens. 1998;12:743-748.
13. Zakopoulos N, Papamichael C, Papaconstantinou H, et al. Isolated clinic hypertension is not an innocent phenomenon: effect on the carotid artery structure. Am J Hypertens. 1999;12:245-250.
14. Karter Y, Curgunlu A, Altinisik S, et al. Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent? Blood Press. 2003;12:307-313.
15. Gomez-Cerezo J, Rios Blanco JJ, Suarez Garcia I, et al. Noninvasive study of endothelial function in white coat hypertension. Hypertension. 2002;40:304-309.
16. Pickering TG. Principles and techniques of blood pressure measurement. Cardiol Clin. 2002;20:207-223.
17. Ernst ME, Bergus GR. Noninvasive 24-hour ambulatory blood pressure monitoring: overview of technology and clinical applications. Pharmacotherapy. 2002;22:597-612.
18. Verdecchia P, Schillaci G, Porcellati C. White-coat hypertension. J Hypertens. 1997;15:99-100.
19. Gottdiener JS, Bednarz J, Devereux R, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr. 2004;17:1086-1119.
20. Devereux RB, Casale PN, Kligfield P, et al. Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. Am J Cardiol. 1986;57:1388-1393.
21. Muldoon MF, Nazzaro P, Sutton-Tyrrell K, et al. White-coat hypertension and carotid artery atherosclerosis: a matching study. Arch Intern Med. 2000;160:1507-1512.
22. Bazett H. An analysis of time relations of electrocardiograms. Heart. 1920;7:353-370.
23. Glen SK, Elliott HL, Curzio JL et al. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet. 1996;348:654-657.
24. Sega R, Trocino G, Lanzarotti A, et al. Alterations of Cardiac Structure in Patients With Isolated Office, Ambulatory, or Home Hypertension Data From the General Population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001;104:1385-1392.